1
Targeted therapies for HPV‐associated cervical cancer: Harnessing the potential of exosome‐based chipsets in combating leukemia and HPV‐mediated cervical cancer
Swastika Maitra, Nobendu Mukerjee, Hanan M. Alharbi, Arabinda Ghosh, Athanasios Alexiou, Nanasaheb D. Thorat
Journal of Medical Virology, 9.04.2024
Tilføjet 9.04.2024
2
Revolutionizing Human papillomavirus (HPV)‐related cancer therapies: Unveiling the promise of Proteolysis Targeting Chimeras (PROTACs) and Proteolysis Targeting Antibodies (PROTABs) in cancer nano‐vaccines
Nobendu Mukerjee, Swastika Maitra, Sukhamoy Gorai, Arabinda Ghosh, Athanasiosis Alexiou, Nanasaheb D. Thorat
Journal of Medical Virology, 5.10.2023
Tilføjet 5.10.2023
3
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial
Jesper D. Gunst, Jesper F. Højen, Marie H. Pahus, Miriam Rosás-Umbert, Birgitte Stiksrud, James H. McMahon, Paul W. Denton, Henrik Nielsen, Isik S. Johansen, Thomas Benfield, Steffen Leth, Jan Gerstoft, Lars Østergaard, Mariane H. Schleimann, Rikke Olesen, Henrik Støvring, Line Vibholm, Nina Weis, Anne M. Dyrhol-Riise, Karen B. H. Pedersen, Jillian S. Y. Lau, Dennis C. Copertino Jr, Noemi Linden, Tan T. Huynh, Victor Ramos, R. Brad Jones, Sharon R. Lewin, Martin Tolstrup, Thomas A. Rasmussen, Michel C. Nussenzweig, Marina Caskey, Dag Henrik Reikvam, Ole S. Søgaard
Nature, 12.09.2023
Tilføjet 12.09.2023